The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders
NCT02804334 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 29
Last updated 2018-11-01
Summary
The goal of this project is to study \~45 molecules in blood cells that may differentiate patients with bipolar disorder from healthy controls.
Conditions
Interventions
- PROCEDURE
-
Psychiatric Questionnaires
- PROCEDURE
-
Blood draw
Sponsors & Collaborators
-
CellPrint Biotechnology
collaborator OTHER -
University Hospitals Cleveland Medical Center
lead OTHER
Principal Investigators
-
Keming Gao, MD, PhD · University Hospitals Cleveland Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2018-10-31
- Completion
- 2018-10-31
Countries
- United States
Study Locations
More Related Trials
-
Mood Stabilizer-induced Metabolic Abnormalities in Bipolar Disorder
NCT04486092 ·Status: UNKNOWN ·Phase: NA
-
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
NCT06373016 ·Status: RECRUITING ·Phase: NA
-
Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.
NCT00007761 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder
NCT07031817 ·Status: RECRUITING ·Phase: NA
-
Bipolar Disorder Study for Men and Women
NCT00056277 ·Status: COMPLETED ·Phase: PHASE3
-
Natural History of Depression, Bipolar Disorder and Suicide Risk
NCT06462196 ·Status: RECRUITING
-
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
NCT02893371 ·Status: TERMINATED
-
Clinical Evaluation of the Antidepressant Effect of the Use of Probiotics in Bipolar Disorder
NCT05762887 ·Status: COMPLETED ·Phase: NA
-
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
NCT02970721 ·Status: COMPLETED
-
Pioglitazone and Quetiapine XR Pharmacogenetic Study
NCT01342380 ·Status: COMPLETED
-
Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder
NCT02456896 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Genetics of Bipolar Disorder
NCT00001174 ·Status: ACTIVE_NOT_RECRUITING
-
PET and MRI Brain Imaging of Bipolar Disorder
NCT01880957 ·Status: COMPLETED ·Phase: NA
-
Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR
NCT00879307 ·Status: UNKNOWN ·Phase: PHASE3
-
Functional and Neurochemical Brain Changes Bipolar Depression
NCT00608296 ·Status: COMPLETED
-
Study of a Vestibular Biomarker of Phase in Bipolar Disorder
NCT02827045 ·Status: ENROLLING_BY_INVITATION
-
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
NCT06081426 ·Status: RECRUITING ·Phase: NA
-
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
NCT03336918 ·Status: ACTIVE_NOT_RECRUITING
-
Bipolar Disorder and Oxidative Stress Injury Mechanism - Clinical Big Data Analysis Based on Machine Learning
NCT03949218 ·Status: COMPLETED
-
Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder
NCT01282281 ·Status: COMPLETED
-
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
NCT01272531 ·Status: COMPLETED
-
EVALUATION OF BLOOD BIOMARKER-BASED DIAGNOSTIC AID IN OUTPATIENTS SUFFERING FROM DEPRESSION
NCT06369805 ·Status: COMPLETED
-
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder
NCT00327756 ·Status: WITHDRAWN ·Phase: PHASE2
-
Prevention of Mood Disorders by Folic Acid Supplementation
NCT00459264 ·Status: COMPLETED ·Phase: NA
-
Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder
NCT00608075 ·Status: UNKNOWN ·Phase: PHASE4